Skip To Main Content
Yinuo Tan on Muck Rack

Yinuo Tan

As seen in: Frontiers, Frontiers in Immunology, MDPI, Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yinuo

Contact Yinuo, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

PD-1 blockade combined with anlotinib and bicalutamide for metastatic primary cutaneous apocrine carcinoma: a case report and literature review

|
By Yuqi Jin, Linglin Fu, Xuan Leng, Yinuo Tan
| Frontiers in Immunology
Abstract Background: Primary cutaneous apocrine carcinoma (PCAC) is a rare malignant adnexal tumor with substantial diagnostic complexity and no established systemic therapy standard for advanced disease.Evidence for endocrine therapy, targeted therapy, and immune checkpoint inhibitors is limited to small series and case reports. Case presentation: A patient presented with a pruritic erythematous plaque on the left chest wall that progressively enlarged over one year.
Open in Who Shared Issue with article?

Frontiers | Donafenib intolerance in hepatocellular carcinoma: severe hand-foot skin reaction and successful switch to lenvatinib - a case report and literature review

|
By Ying Chen, Linglin Fu, Ping Song, Yinuo Tan, Yuqi Jin
| Frontiers
CASE REPORT article Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1728098 This article is part of the Research TopicDrug Repurposing: The New Frontier in Fighting CancerView all 3 articles Introduction Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, and many patients present at stages unsuitable for curative surgery or ablation (1, 2). For these patients, systemic therapy is central to care.
Open in Who Shared Issue with article?

Hepatic micropeptide modulates mitochondrial RNA processing machinery in hepatocellular carcinoma

|
By Linyu Zhu, Fangzhou Liu, Chengyu Shi, Xinwan Su, Manman Tan, Shaofang Xie, Meng Yu, Sailan Zou, Yinuo Tan, Shanshan Xie, Jian Liu, Qingfeng Yan, Dante Neculai, Qiming Sun, Wei Liu, Yuan Ding, Xianghui Fu, Jianzhong Shao, Xu Li, Kefeng Ding, Ying Yuan, Tianhua Zhou, Aifu Lin
| Cell Press Verified
1Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000, China 2MOE Laboratory of Biosystem Homeostasis and Protection, College of Life Sciences, Zhejiang University, Hangzhou, Zhejiang 310000, China 3Cancer Center, Zhejiang University, Hangzhou, Zhejiang 310000, China 4Department of Medical Oncology, the Second Affiliated Hospital, Zhejiang University School...
Open in Who Shared Issue with article?
See all 4 articles